Vertex Pharmaceuticals Incorporated (LON:0QZU)
London · Delayed Price · Currency is GBP · Price in USD 463.25
+5.51 (1.20%)
Feb 12, 2026, 5:10 PM GMT
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 85.77 billion as of February 12, 2026. Its market cap has decreased by -6.33% in one year.
Market Cap
85.77B
Enterprise Value
78.31B
Revenue
8.72B
Ranking
n/a
PE Ratio
31.37
Stock Price
463.25
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 85.77B, an increase of 167,382.31%. That is a compound annual growth rate of 23.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 86.03B | 0.66% |
| Dec 31, 2025 | 85.46B | 3.17% |
| Dec 31, 2024 | 82.84B | 0.64% |
| Dec 29, 2023 | 82.31B | 33.80% |
| Dec 30, 2022 | 61.52B | 49.20% |
| Dec 31, 2021 | 41.23B | -8.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 35.66B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.41B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |